Tyrosine Kinase Inhibitor Conjugated RAP-based Peptide (Horizon Therapeutics)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTyrosine Kinase Inhibitor Conjugated RAP-based Peptide (Horizon Therapeutics)
Drug Alias NameTKI conjugated RAP peptide (HepTide) (Raptor)Tyrosine Kinase Inhibitor Conjugated RAP-based Peptide (Horizon Pharma)Tyrosine Kinase Inhibitor Conjugated RAP-based Peptide (Raptor)TKI conjugated RAP peptide (HepTide) (Horizon Pharma)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionAnticancer protein kinase inhibitors
TargetsUpdating
Therapy Area/IndicationsCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHorizon Orphan Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHorizon Orphan LlcHorizon Therapeutics PLC
Active IndicationsN/A
Inactive IndicationsCarcinoma, Hepatocellular

Other Information

ATC CodeN/A
Related LinksN/A